US Stock MarketDetailed Quotes

SYRS Syros Pharmaceuticals

Watchlist
  • 0.2100
  • -0.0247-10.52%
Close Jan 8 16:00 ET
  • 0.2081
  • -0.0019-0.90%
Post 17:19 ET
5.63MMarket Cap-0.07P/E (TTM)

Syros Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
35.06%-20.69M
-32.52%-29.67M
15.73%-31.1M
10.85%-109.71M
40.28%-18.56M
10.98%-31.86M
14.49%-22.39M
-22.93%-36.9M
-23.63%-123.07M
-35.33%-31.08M
Net income from continuing operations
84.07%-6.4M
35.66%-23.33M
84.41%-3.71M
-73.87%-164.57M
-1,248.64%-64.38M
-32.69%-40.14M
-5.15%-36.26M
5.40%-23.79M
-9.35%-94.65M
79.95%-4.77M
Operating gains losses
-447.83%-20.3M
-244.35%-4.48M
-204.60%-27M
197.56%37.28M
220.95%37.2M
220.45%5.84M
2,090.38%3.11M
-262.13%-8.87M
-129.03%-38.21M
-1,099.06%-30.76M
Depreciation and amortization
-46.90%325K
-49.08%331K
-47.65%334K
-16.78%2.25M
-50.07%352K
-7.13%612K
-1.66%650K
-6.31%638K
-10.34%2.71M
-8.80%705K
Other non cash items
0.00%147K
-18.79%121K
-24.38%152K
-31.79%650K
-23.50%153K
-39.75%147K
-42.25%149K
-19.92%201K
34.99%953K
8.11%200K
Change In working capital
318.60%3.91M
-150.35%-3.92M
60.24%-2.86M
191.63%5.06M
953.37%6.26M
61.12%-1.79M
62.77%7.79M
-14.46%-7.2M
47.96%-5.52M
212.93%594K
-Change in receivables
--0
--0
--0
31.83%1.69M
2,062.34%1.67M
-82.57%91K
-98.99%9K
65.02%-71K
298.30%1.29M
-88.21%77K
-Change in prepaid assets
871.79%301K
-152.33%-2.06M
18.06%1.56M
169.11%1.94M
210.14%1.48M
97.08%-39K
-144.31%-816K
549.26%1.32M
-182.11%-2.81M
-263.94%-1.34M
-Change in payables and accrued expense
1,070.90%3.78M
-122.59%-1.69M
46.41%-4.2M
-42.20%2.95M
181.53%2.99M
119.19%323K
-17.60%7.48M
-134.45%-7.83M
4.78%5.11M
-69.65%1.06M
-Change in other current assets
-18.97%94K
-96.28%90K
-94.01%42K
256.04%3.76M
130.99%521K
78.46%116K
633.77%2.42M
307.40%701K
-101.25%-2.41M
-234.86%-1.68M
-Change in other current liabilities
----
----
-12.82%-264K
-13.09%-959K
----
----
----
-13.04%-234K
---848K
---227K
-Change in other working capital
88.43%-264K
----
----
26.00%-4.33M
-79.08%566K
-16.02%-2.28M
63.41%-1.53M
54.94%-1.09M
53.71%-5.85M
154.20%2.71M
Cash from discontinued investing activities
Operating cash flow
35.06%-20.69M
-32.52%-29.67M
15.73%-31.1M
10.85%-109.71M
40.28%-18.56M
10.98%-31.86M
14.49%-22.39M
-22.93%-36.9M
-23.63%-123.07M
-35.33%-31.08M
Investing cash flow
Cash flow from continuing investing activities
0
-23.86%25.07M
4.30%-24.64M
-44.43%37.34M
-95.97%1.52M
362.53%28.64M
107.21%32.92M
-448.75%-25.75M
227.60%67.19M
15,496.33%37.72M
Net PPE purchase and sale
--0
-3,000.00%-29K
112.34%29K
203.79%1.29M
325.82%1.52M
--0
100.90%1K
-83.59%-235K
0.32%-1.24M
-175.10%-674K
Net investment purchase and sale
--0
-24.15%24.97M
3.31%-24.67M
-47.32%36.05M
--0
339.26%28.64M
105.76%32.92M
-439.68%-25.51M
233.10%68.43M
--38.4M
Net other investing changes
--0
----
----
----
----
----
----
----
----
----
Cash from discontinued investing activities
Investing cash flow
--0
-23.86%25.07M
4.30%-24.64M
-44.43%37.34M
-95.97%1.52M
362.53%28.64M
107.21%32.92M
-448.75%-25.75M
227.60%67.19M
15,496.33%37.72M
Financing cash flow
Cash flow from continuing financing activities
0
-70.71%41K
-400.00%-265K
-66.83%43.46M
505.31%43.38M
-100.00%-5K
162.78%140K
43.01%-53K
85.85%131.05M
-11,248.96%-10.7M
Net issuance payments of debt
--0
--0
--0
77.66%-65K
96.00%-3K
93.24%-5K
94.44%-4K
24.29%-53K
-9.81%-291K
-8.70%-75K
Net common stock issuance
----
----
----
-63.85%43.27M
----
----
----
----
70.15%119.68M
---8.31M
Proceeds from stock option exercised by employees
--0
----
----
17.89%257K
4.63%113K
--0
----
----
-54.58%218K
-36.47%108K
Net other financing activities
--0
---74K
---265K
----
----
----
----
----
27,997.56%11.44M
-48,460.00%-2.43M
Cash from discontinued financing activities
Financing cash flow
--0
-70.71%41K
-400.00%-265K
-66.83%43.46M
505.31%43.38M
-100.00%-5K
162.78%140K
43.01%-53K
85.85%131.05M
-11,248.96%-10.7M
Net cash flow
Beginning cash position
-31.59%81.08M
-20.59%85.64M
-16.95%141.65M
78.80%170.55M
-33.97%115.31M
90.71%118.53M
48.43%107.85M
78.80%170.55M
-46.13%95.39M
47.35%174.62M
Current changes in cash
-541.92%-20.69M
-142.70%-4.56M
10.68%-56M
-138.46%-28.91M
747.97%26.34M
-102.87%-3.22M
201.58%10.68M
-175.89%-62.7M
192.02%75.17M
82.42%-4.07M
End cash Position
-47.62%60.39M
-31.59%81.08M
-20.59%85.64M
-16.95%141.65M
-16.95%141.65M
-33.97%115.31M
90.71%118.53M
48.43%107.85M
78.80%170.55M
78.80%170.55M
Free cash flow
35.06%-20.69M
-32.53%-29.67M
16.26%-31.1M
11.53%-109.98M
41.43%-18.6M
11.79%-31.86M
14.85%-22.39M
-23.19%-37.14M
-23.34%-124.31M
-36.80%-31.76M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 35.06%-20.69M-32.52%-29.67M15.73%-31.1M10.85%-109.71M40.28%-18.56M10.98%-31.86M14.49%-22.39M-22.93%-36.9M-23.63%-123.07M-35.33%-31.08M
Net income from continuing operations 84.07%-6.4M35.66%-23.33M84.41%-3.71M-73.87%-164.57M-1,248.64%-64.38M-32.69%-40.14M-5.15%-36.26M5.40%-23.79M-9.35%-94.65M79.95%-4.77M
Operating gains losses -447.83%-20.3M-244.35%-4.48M-204.60%-27M197.56%37.28M220.95%37.2M220.45%5.84M2,090.38%3.11M-262.13%-8.87M-129.03%-38.21M-1,099.06%-30.76M
Depreciation and amortization -46.90%325K-49.08%331K-47.65%334K-16.78%2.25M-50.07%352K-7.13%612K-1.66%650K-6.31%638K-10.34%2.71M-8.80%705K
Other non cash items 0.00%147K-18.79%121K-24.38%152K-31.79%650K-23.50%153K-39.75%147K-42.25%149K-19.92%201K34.99%953K8.11%200K
Change In working capital 318.60%3.91M-150.35%-3.92M60.24%-2.86M191.63%5.06M953.37%6.26M61.12%-1.79M62.77%7.79M-14.46%-7.2M47.96%-5.52M212.93%594K
-Change in receivables --0--0--031.83%1.69M2,062.34%1.67M-82.57%91K-98.99%9K65.02%-71K298.30%1.29M-88.21%77K
-Change in prepaid assets 871.79%301K-152.33%-2.06M18.06%1.56M169.11%1.94M210.14%1.48M97.08%-39K-144.31%-816K549.26%1.32M-182.11%-2.81M-263.94%-1.34M
-Change in payables and accrued expense 1,070.90%3.78M-122.59%-1.69M46.41%-4.2M-42.20%2.95M181.53%2.99M119.19%323K-17.60%7.48M-134.45%-7.83M4.78%5.11M-69.65%1.06M
-Change in other current assets -18.97%94K-96.28%90K-94.01%42K256.04%3.76M130.99%521K78.46%116K633.77%2.42M307.40%701K-101.25%-2.41M-234.86%-1.68M
-Change in other current liabilities ---------12.82%-264K-13.09%-959K-------------13.04%-234K---848K---227K
-Change in other working capital 88.43%-264K--------26.00%-4.33M-79.08%566K-16.02%-2.28M63.41%-1.53M54.94%-1.09M53.71%-5.85M154.20%2.71M
Cash from discontinued investing activities
Operating cash flow 35.06%-20.69M-32.52%-29.67M15.73%-31.1M10.85%-109.71M40.28%-18.56M10.98%-31.86M14.49%-22.39M-22.93%-36.9M-23.63%-123.07M-35.33%-31.08M
Investing cash flow
Cash flow from continuing investing activities 0-23.86%25.07M4.30%-24.64M-44.43%37.34M-95.97%1.52M362.53%28.64M107.21%32.92M-448.75%-25.75M227.60%67.19M15,496.33%37.72M
Net PPE purchase and sale --0-3,000.00%-29K112.34%29K203.79%1.29M325.82%1.52M--0100.90%1K-83.59%-235K0.32%-1.24M-175.10%-674K
Net investment purchase and sale --0-24.15%24.97M3.31%-24.67M-47.32%36.05M--0339.26%28.64M105.76%32.92M-439.68%-25.51M233.10%68.43M--38.4M
Net other investing changes --0------------------------------------
Cash from discontinued investing activities
Investing cash flow --0-23.86%25.07M4.30%-24.64M-44.43%37.34M-95.97%1.52M362.53%28.64M107.21%32.92M-448.75%-25.75M227.60%67.19M15,496.33%37.72M
Financing cash flow
Cash flow from continuing financing activities 0-70.71%41K-400.00%-265K-66.83%43.46M505.31%43.38M-100.00%-5K162.78%140K43.01%-53K85.85%131.05M-11,248.96%-10.7M
Net issuance payments of debt --0--0--077.66%-65K96.00%-3K93.24%-5K94.44%-4K24.29%-53K-9.81%-291K-8.70%-75K
Net common stock issuance -------------63.85%43.27M----------------70.15%119.68M---8.31M
Proceeds from stock option exercised by employees --0--------17.89%257K4.63%113K--0---------54.58%218K-36.47%108K
Net other financing activities --0---74K---265K--------------------27,997.56%11.44M-48,460.00%-2.43M
Cash from discontinued financing activities
Financing cash flow --0-70.71%41K-400.00%-265K-66.83%43.46M505.31%43.38M-100.00%-5K162.78%140K43.01%-53K85.85%131.05M-11,248.96%-10.7M
Net cash flow
Beginning cash position -31.59%81.08M-20.59%85.64M-16.95%141.65M78.80%170.55M-33.97%115.31M90.71%118.53M48.43%107.85M78.80%170.55M-46.13%95.39M47.35%174.62M
Current changes in cash -541.92%-20.69M-142.70%-4.56M10.68%-56M-138.46%-28.91M747.97%26.34M-102.87%-3.22M201.58%10.68M-175.89%-62.7M192.02%75.17M82.42%-4.07M
End cash Position -47.62%60.39M-31.59%81.08M-20.59%85.64M-16.95%141.65M-16.95%141.65M-33.97%115.31M90.71%118.53M48.43%107.85M78.80%170.55M78.80%170.55M
Free cash flow 35.06%-20.69M-32.53%-29.67M16.26%-31.1M11.53%-109.98M41.43%-18.6M11.79%-31.86M14.85%-22.39M-23.19%-37.14M-23.34%-124.31M-36.80%-31.76M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Toll Brothers
TOL
+2.56%
Meritage Homes
MTH
+2.34%
Taylor Morrison Home
TMHC
+1.58%
D.R. Horton
DHI
+1.49%
KB Home
KBH
+1.35%

Unlock the Full List